Public Board papers 31.03.22

Public meeting of the Board of Directors Thursday 27 th January 2022 at 12.45 pm By virtual means

Present: Chair: Chris Outram (CO), Chairman

Kathryn Riddle (KR), Non-executive director Dr Jane Maher (JM), Non-executive Director Robert Ainsworth (RA), Non-executive Director Prof Kieran Walshe (KW), Non-executive Director Grenville Page (GP), Non-executive Director Alveena Malik (AM), Non-executive Director Roger Spencer (RS), Chief Executive Bernie Delahoyde (BD), Chief Operating Officer Eve Lightfoot (EL), Director of Workforce Prof Chris Harrison (CJH), Medical Director and Deputy CEO Dr Neil Bayman (NB), Executive Medical Director Prof Janelle Yorke (JY), Executive Chief Nurse Sally Parkinson (SP), Interim Director of Finance Prof Fiona Blackhall (FB), Director of Research Prof Richard Fuller (RF), Director of Education Deborah Matier, Healthcare Solutions Manager, Amgen Elvira Pyrah Shira Baram, Project Manager, Tissue Biobank Liz Randall, Business Analyst Mike Norcross, Public Governor, Cheshire

In attendance: Jo D’Arcy, Assistant Company Secretary

Nada Khalil, Innovation Manager R&I Matt Bilney, Staff Governor, Nursing

Minutes:

Louise Westcott (LW), Company Secretary

CO noted that we are still in a level 4 incident and in line with the requirement to reduce the burden on staff we are having a shortened meeting. Item Action 01/22 Standard business a Apologies Apologies were received from Tarun Kapur (TK), Non-executive Director b Declarations of Interest No declarations of interest noted. c Minutes of the previous meeting – 25 th November 2021 The minutes were accepted as a correct record.

d Action plan rolling programme, action log & matters arising All items from the rolling programme are noted on the agenda. 02/22 Key Reports a Chief executive’s situation report

2